Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03500484 · ClinicalTrials.gov registry record · Early Phase 1
Effect of Liraglutide on Neural Responses to High Fructose Corn Syrup in Individuals With Obesity.
A Early Phase 1 study, sponsored by Yale University.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 13
- Enrollment target
NCT03500484: Clinical Trial Early Phase 1 study, sponsored by Yale University.
NCT03500484 is a Early Phase 1 study that was terminated before completion, run by Yale University. The registered enrollment target is 13 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03500484, a Early Phase 1 study, was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 13 participants
- Enrollment target
Study Summary
To study the effects of liraglutide on neural responses to high fructose corn syrup (HFCS) in individuals with obesity.
Primary Outcome
To investigate brain response (using fMRI) to acute consumption of sugar sweetened beverages in obese prediabetic adolescents/young adults (age 18-39 yrs), increase in cerebral blood flow was monitored in participants as a binary outcome (increase/no increase).
Interventions
- DRUG Liraglutide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2018-06-06 |
| Est. Completion | 2020-06-25 |
| Phase | Early Phase 1 |
Why NCT03500484 stopped before completion
NCT03500484 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 1 intervention - of which Liraglutide is the first listed.
NCT03500484 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03500484 about?
NCT03500484 is a clinical study titled "Effect of Liraglutide on Neural Responses to High Fructose Corn Syrup in Individuals With Obesity.". To study the effects of liraglutide on neural responses to high fructose corn syrup (HFCS) in individuals with obesity.
What is the current status of trial NCT03500484?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 13 participants. The study started on 2018-06-06. Estimated completion is 2020-06-25.
What interventions are being tested in trial NCT03500484?
The interventions under investigation include: Liraglutide (DRUG).
Who is sponsoring clinical trial NCT03500484?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03500484's enrollment target sits among peer trials
13 1503rd of 2000 higher than 472 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI